1. The impact of CDCA5 expression on the immune microenvironment and its potential utility as a biomarker for PD-L1/PD-1 inhibitors in lung adenocarcinoma
   Young Wha Koh et al, 2024, Translational Oncology CrossRef
2. Clinical evidence for a role of E2F1-induced replication stress in modulating tumor mutational burden and immune microenvironment
   Ke Tan et al, 2023, DNA Repair CrossRef
3. CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1
   Yiquan Xiong et al, 2024, Journal of Translational Medicine CrossRef
4. YAP-mediated mechanotransduction in urinary bladder remodeling: Based on RNA-seq and CUT&Tag
   Xingpeng Di et al, 2023, Frontiers in Genetics CrossRef
5. GNPNAT1 promotes the stemness of breast cancer and serves as a potential prognostic biomarker
   Hao Hu et al, 2023, Oncology Reports CrossRef
6. Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinoma
   Liming Zhang et al, 2024, BMC Cancer CrossRef
7. Research Progress of the Function of CDCA5 and Its Role in Cancer Progression
   锦博 范, 2023, Advances in Clinical Medicine CrossRef
8. Immune-related biomarkers predict the prognosis and immune response of breast cancer based on bioinformatic analysis and machine learning
   Xuewei Zheng et al, 2023, Functional & Integrative Genomics CrossRef
9. Gene targets with therapeutic potential in hepatocellular carcinoma
   Syifaus Shodry et al, 2024, World Journal of Gastrointestinal Oncology CrossRef
10. Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer
    Yousif A. Kariri et al, 2022, Cancers CrossRef
11. Roles, biological functions, and clinical significances of RHPN1-AS1 in cancer
    Fan Yu et al, 2023, Pathology - Research and Practice CrossRef